GEHC Trading Analysis - 10/30/2026 11:00 AM — TRU-SENTIMENT

News Headlines & Context

Recent general-knowledge context for GEHC (GE HealthCare) indicates the following themes that may relate to the embedded data:

• GE HealthCare reported steady demand in imaging and ultrasound segments through prior quarters, with continued supply-chain normalization cited in industry coverage.
• The company went ex-dividend on 2026-10-23 (per embedded fundamentals), with a $0.16 dividend and 0.21% yield, a minor near-term shareholder event.
• Broad medtech sector has seen renewed investor interest amid easing rate expectations, potentially supporting the sharp late-October price jump in GEHC.
• No major earnings date is indicated in the embedded data; next scheduled fiscal year end is 2025-12-01 per fundamentals, suggesting typical Q4 reporting cadence.
• The post-ex-dividend price surge on 2026-10-28 (open $76.00 vs prior close $71.13) aligns with a momentum shift rather than a specific headline catalyst in the provided data.

This news context is separated from the strict data analysis below, which uses only embedded JSON.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS JSON:

• Trailing P/E: 16.10; Trailing EPS: $4.74; Market Cap: $34,855,318,420; Shares Out: 452,138,000.
• Dividend Yield: 0.21% (Rate $0.16); Ex-Dividend: 2026-10-23; Beta: 0.82 (low volatility vs market).
• 52-Week High: $89.77; 52-Week Low: $58.75; Institutional Ownership: 69.61%.
• Average Volume: 3,852,000; Historical Volatility: 29.09%; Fiscal Year End: 2025-12-01.
• PEG Ratio, Forward P/E, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: all null/not provided.
• Analyst Consensus & Target Price: not provided (null).

Fundamentals show a modestly valued (P/E 16.10) large-cap medtech with low beta (0.82) and majority institutional holding (69.61%). The lack of margin/ growth data limits depth, but the P/E below typical tech peaks and sub-1 beta suggest defensive characteristics. This diverges from the embedded technical spike (RSI 81, price above upper Bollinger) which shows speculative momentum not explained by fundamental fields.

Current Market Position

From DAILY and MINUTE data:

• Current daily close (2026-10-29): $76.71; Minute bars end 2026-10-30 10:30 at $77.43 (open $77.47, high $77.47, low $77.43).
• Daily jump: 2026-10-27 close $71.13 -> 2026-10-28 open $76.00, close $76.09 (volume 7,199,205 vs 20d avg 2,426,315).
• 30-day range high $77.88, low $63.31; current price near top of range.
• Minute bars show tight narrowing: 2026-10-30 10:10 $77.71 to 10:30 $77.43 on declining volume (26,403 to 59,918), mild intraday pullback from $77.71.

Technical Analysis

• SMA alignment: 5 > 20 > 50 ($73.52 > $69.09 > $68.41) - bullish stack, no bear cross.
• RSI 81.00 = overbought; momentum extreme, risk of mean reversion.
• MACD positive (1.95 > 1.56 signal, hist 0.39) = bullish momentum continuing.
• Price $76.71 above BB upper $76.06 = expansion breakout, statistically extended.
• 30-day range: price at $76.71 is 92% of range from $63.31 to $77.88 (near top).

True Sentiment Analysis (Delta 40-60 Options)

From GEHC_options_20261030_1059.json:

Call Volume: $26,575 (97.9%) Put Volume: $580 (2.1%) Total: $27,155

• Sentiment: Bullish (call contracts 95, put 2; call trades 11, put 1).
• Pure directional conviction strongly favors calls (97.9% dollar vol) - near-term upside expectation.
• Filter ratio 1.2% of total options analyzed (12 of 1026) - small but decisive flow.
• Divergence: Option spread JSON notes "Divergence detected between technical indicators and options sentiment" with advice to wait for alignment; however technicals show overbought not "no clear direction" per indicator file. Sentiment bullish vs RSI extreme suggests possible blow-off top or continuation.

Key Price Levels (Observational Only)